Managing Hemophilia With Alhemo

If you live with hemophilia, you know it’s not just “a bleeding problem” it’s a full-time job.
Every bump is suspicious, every dental visit needs a game plan, and your travel bag has more
medical supplies than snacks. The good news? Treatment options keep getting better. One of the
newest kids on the block is Alhemo (concizumab-mtci), a non-factor therapy designed
to prevent or reduce bleeding episodes in people with hemophilia A or B.

In this guide, we’ll break down what Alhemo is, how it works, who it may be right for, and how to
fold it into real life from daily routines to travel and sports. We’ll keep things practical,
clear, and yes, just a little bit fun, because your treatment plan shouldn’t read like a tax
form.

Understanding Hemophilia Today

Hemophilia is a genetic bleeding disorder where your body is missing or has very low levels of
key clotting proteins called factor VIII (hemophilia A) or
factor IX (hemophilia B). Without enough of these factors, bleeding lasts longer
and can happen internally, especially into joints and muscles. Over time, repeated joint bleeds
can lead to pain, stiffness, and arthritis-like damage if not well controlled.

The traditional “gold standard” treatment has been factor replacement therapy:
you infuse the missing factor through a vein, either when you have a bleed (on-demand) or on a
regular schedule (prophylaxis) to prevent bleeds. While effective, factor infusions can be
time-consuming, require good IV access, and may still leave people with bleed “breakthroughs.”

Another challenge is the development of inhibitors antibodies the body makes
against factor VIII or IX. These inhibitors neutralize factor replacement products, making them
less effective or ineffective. People with inhibitors often need special “bypassing agents” and
historically have had a tougher time keeping bleeds under control.

In the last decade, we’ve seen a shift toward non-factor therapies given by
injection under the skin. These treatments, including Alhemo, work differently from factor
replacement but aim at the same goal: fewer bleeds, fewer emergencies, and a more predictable
life.

Meet Alhemo: What It Is and How It Works

What Is Alhemo (Concizumab-mtci)?

Alhemo is a prescription medicine used for
routine prophylaxis that means regularly scheduled prevention to reduce or
prevent bleeding episodes in adults and adolescents
12 years of age and older with hemophilia A or B, with or
without inhibitors.

Instead of going into a vein, Alhemo is given as a once-daily subcutaneous injection,
similar to how some people take insulin. It comes in prefilled pens or syringes, designed to
simplify the process and avoid mixing vials or dealing with IV lines.

How Does Alhemo Work?

To understand Alhemo, you don’t need a hematology degree but a quick overview helps. In normal
clotting, several proteins work together like members of a relay team. One of the regulators in
this system is called tissue factor pathway inhibitor (TFPI). TFPI acts as a
brake so clotting doesn’t run wild.

In hemophilia A or B, the balance is already tipped toward bleeding. Alhemo (concizumab) is a
monoclonal antibody that targets TFPI and eases that “brake,” helping your
clotting system generate more thrombin and form stronger clots, even when factor VIII or IX
levels are low. In other words, it doesn’t replace factor; it rebalances the system.

Clinical trials in people with hemophilia A and B, both with and without inhibitors, have shown
that Alhemo prophylaxis can significantly reduce annual bleeding rates compared with on-demand
bypassing agents or on-demand factor replacement. That translates into fewer joint bleeds, fewer
emergency treatments, and less disruption to daily life.

Who Is Alhemo For?

According to current approvals, Alhemo is indicated for:

• Adults and adolescents aged 12 years and older
• Diagnosed with hemophilia A or hemophilia B
• With or without factor VIII or IX inhibitors
• Who are using it for routine prophylaxis to prevent or reduce bleeding episodes

It is not currently approved for children under 12 years of age, and it has not
been established for people undergoing immune tolerance induction (ITI). Your hematologist will
review your full history, inhibitor status, previous treatments, and lifestyle before deciding if
Alhemo makes sense for you.

Benefits of Managing Hemophilia With Alhemo

Every therapy has pros and cons, but Alhemo brings some very real advantages to the table for
many people:

1. Fewer Bleeds, Less Joint Damage

In clinical studies, people on Alhemo experienced a strong reduction in
annualized bleeding rates (ABR) compared with those treated on-demand with
bypassing agents or factor concentrates. Fewer bleeds don’t just mean fewer chaotic nights in the
emergency room; they also mean less cumulative damage to joints and muscles over time, which can
translate to better long-term mobility and less pain.

2. Subcutaneous Dosing Instead of IV Access

Many people living with hemophilia will tell you that finding a vein or living with a port
can be the hardest part of staying on prophylaxis. Because Alhemo is given
under the skin (subcutaneously), there’s no need for venous access and no need
to mix factor before each dose. For some, this is the difference between “I try to stay on
schedule” and “I actually stay on schedule.”

3. A Simple, Predictable Daily Routine

Alhemo is designed for once-daily dosing. While daily injections do require
consistency, they also create predictable habits. Many people find that anchoring their injection
to a daily activity brushing teeth, morning coffee, or a nightly show makes adherence easier.
When prophylaxis becomes just another part of your routine, it’s easier to stay protected.

4. Works for People With and Without Inhibitors

One of Alhemo’s biggest advantages is that it’s approved for people with
hemophilia A or B, with or without inhibitors. That means if you’ve struggled
with inhibitors making standard factor less effective, you may still have a strong prophylactic
option in Alhemo. It doesn’t erase the complexity of inhibitor management but gives you and your
care team another powerful tool.

Getting Started: Talking With Your Hemophilia Care Team

If you’re curious about Alhemo, your first stop is your hematologist or
comprehensive hemophilia treatment center. Here are key questions and points to discuss:

• Am I a good candidate? Your team will consider your type of hemophilia, age,
  inhibitor status, and current treatment plan.
• What are realistic goals? You might aim for fewer joint bleeds, better
  mobility, or feeling safe doing certain activities you currently avoid.
• How will we transition? Switching from factor prophylaxis or on-demand
  therapy to Alhemo may involve overlap or specific timing. Your team will map this out.
• What about emergencies? You should have a clear written plan for breakthrough
  bleeds, trauma, and surgery.
• Insurance and support programs. Ask about coverage, copay assistance, and
  patient support services that may help with training and logistics.

Bring your questions, your treatment history, and maybe even your phone notes the more your
care team knows about your bleeds and daily life, the better they can personalize your plan.

Everyday Life on Alhemo

Building a Daily Routine You Can Actually Keep

Consistency is where Alhemo shines and where real life sometimes tries to sabotage you. A few
practical strategies:

• Pick a “non-negotiable” time. Morning people might take their dose with
  breakfast. Night owls might prefer a bedtime injection.
• Use reminders. Smartphone alarms, reminder apps, or a simple calendar can help
  keep you on track.
• Keep supplies visible and organized. A small, designated basket or drawer with
  pens/syringes, alcohol swabs, and a sharps container makes everything easier.

Injection Technique and Site Care

Your care team will train you on how to inject Alhemo safely. Typical guidance
includes rotating injection sites, cleaning the skin, and disposing of needles in a sharps
container. Mild redness or soreness at the injection site can happen; if reactions are severe or
persistent, let your team know.

Breakthrough Bleeds and Other Medications

Even with excellent prophylaxis, breakthrough bleeds can still occur. Your
hematologist will give you a clear plan for which factor or bypassing agent to use, in what
situation, and how to dose it safely alongside Alhemo.

This is important: combining non-factor therapies like Alhemo with high doses of factor
concentrates or bypassing agents can raise the risk of clotting complications. Never layer
treatments or change doses on your own. If you’re unsure, call your treatment center or go to the
emergency department and show them your treatment plan.

Side Effects and Safety: What You Need to Know

Like every prescription medication, Alhemo has potential side effects and risks.
Your care team will review the official safety information with you, but common discussions
usually include:

• Injection site reactions such as redness, swelling, itching, or mild pain
• Headache, fever, or fatigue in some people, especially when starting therapy
• Allergic reactions, which can be serious; symptoms like difficulty breathing,
  swelling of the face or throat, or severe rash require emergency care
• Risk of blood clots (thrombosis), particularly if used together with certain
  other clotting treatments in high doses

Get clear instructions from your hematologist on:

• Which symptoms require an urgent call to the clinic
• Which symptoms require immediate emergency care
• How to handle a missed dose

And never be shy about asking “Is this normal?” your care team would rather answer questions
early than manage complications later.

Lifestyle Tips for Thriving With Hemophilia on Alhemo

Good prophylaxis is only one piece of the puzzle. To truly manage hemophilia well,
it helps to think about the rest of your lifestyle too.

Staying Active Without Overdoing It

Moderate, joint-friendly exercise can actually protect your joints by strengthening the muscles
around them. Many people with hemophilia do well with:

• Swimming or water aerobics
• Walking, cycling, or using an elliptical machine
• Light strength training with proper supervision

Contact sports and high-impact activities may still be risky, even on Alhemo. Talk with your
care team about what’s safe for you personally and don’t decide based solely on what your
friend at the gym can do.

Dental Care and Everyday “Small” Procedures

Dental work and minor procedures can still trigger bleeds. Let all your healthcare providers
know you have hemophilia and are on Alhemo. Your hematologist might recommend pre-treatment with
factor, antifibrinolytics, or specific precautions based on the procedure.

Traveling With Alhemo

Travel is absolutely possible it just takes planning:

• Pack extra Alhemo pens/syringes, supplies, and a backup treatment plan.
• Carry a letter from your hematologist and a summary of your diagnosis and meds.
• Keep medication in your carry-on and follow storage instructions.
• Know where the nearest hemophilia treatment center or major hospital is at your destination.

With a good plan, vacations are about beaches and museums again, not about stressing over where
you’d go if something happens.

Real-Life Experiences: Living With Hemophilia and Alhemo

Every person’s journey is unique, but certain themes come up again and again when people switch
to a subcutaneous prophylaxis like Alhemo. The stories below are composites based on common
experiences reported in the hemophilia community not real individuals, but very real scenarios.

“I Finally Got My Evenings Back” – The Teen With Inhibitors

Imagine a 16-year-old with severe hemophilia A and inhibitors. For years, his evenings were
dominated by infusions. His parents juggled work, his siblings’ schedules, and his treatments.
Sports felt risky, sleepovers required a medical briefing, and he often felt like “the fragile
kid” in the room.

After transitioning to Alhemo, the family still took hemophilia seriously, but the rhythm of
daily life changed. Instead of setting up an IV line, they did a quick subcutaneous injection
before school. Joint bleeds became far less frequent. He still avoided full-contact football,
but he could play non-contact basketball at school, walk without worrying about every step, and
say “yes” to weekend plans without calculating infusion timing in his head.

Emotionally, the shift was big. He described feeling less “medicalized” and more like a regular
teenager who happened to have a condition not the other way around. His parents reported less
burnout and more family time that wasn’t centered around treatment.

“Travel Stopped Being a Production” – The Adult With Hemophilia B

A man in his 30s with hemophilia B used to think about business trips in terms of coolers, extra
factor, and “Will TSA give me a hard time?” He’d often skip prophylaxis doses on hectic travel
days, then deal with a joint bleed later as his body’s way of saying, “Nice try.”

Once he switched to Alhemo, travel planning changed. He stored his prefilled pens appropriately,
packed backup supplies, and set a daily alarm on his phone. The act of taking his medication
became a quick, predictable step rather than a production. He still carried a travel letter and
had an emergency factor plan for breakthrough bleeds, but he reported far fewer “trip-ruining”
bleeds and less anxiety about every bumped elbow or long flight.

“Caregiving Got Simpler” – The Parent Perspective

For caregivers, especially parents, the emotional load of hemophilia can be heavy. One mother of
a teen described feeling constantly torn between wanting to protect her child and wanting to let
him live a normal life. Factor infusions meant a lot of negotiation: “If we do your infusion
now, we can’t be late for school,” or “We’ll skip this event because I’m worried about your
joints today.”

With Alhemo, she still worried that part doesn’t vanish overnight but the logistics became
easier. Training on subcutaneous injections gave her and her son more independence. As he grew
older, he was able to learn self-injection, which gave him a sense of control and pride. Their
conversations gradually shifted from “Did we treat?” to “What do you want to do this weekend?”

What These Experiences Have in Common

These composite stories share a few threads:

• Adherence improves when treatment fits life better. Fewer steps between “I
  should treat” and “I actually did it” usually means better protection.
• Fewer bleeds change more than joint scores. They change how people say “yes”
  to opportunities, school, work, and social life.
• Support is still crucial. Even with more convenient treatments, education,
  mental health support, and community connections remain key to thriving.

Alhemo is not a magic wand, and it won’t be the right fit for everyone. But for many, it can be
part of a more flexible, less disruptive hemophilia management plan.

Putting It All Together

Managing hemophilia today is about more than just reacting to bleeds. It’s about
planning ahead, protecting your joints, and designing a life where your
treatment whether it’s Alhemo, factor, or something else works with your goals
instead of constantly getting in the way.

If you’re considering Alhemo, start by talking with your hematologist. Ask about your bleed
history, your joint health, your risk factors, and your personal goals. Bring up your daily
realities: work, school, caregiving, travel, sports. Your treatment plan should fit the life you
actually live, not an idealized version of it.

With the right combination of modern prophylaxis, smart lifestyle choices, and a strong support
team, living with hemophilia can be less about constant crisis control and more about getting on
with the business of being you.